These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 26507303)
21. Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis. Ungprasert P; Wijarnpreecha K; Thongprayoon C Indian J Dermatol Venereol Leprol; 2018; 84(1):22-26. PubMed ID: 29185440 [TBL] [Abstract][Full Text] [Related]
22. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Ambrosino P; Tarantino L; Di Minno G; Paternoster M; Graziano V; Petitto M; Nasto A; Di Minno MN Thromb Haemost; 2017 Jan; 117(1):139-148. PubMed ID: 27761574 [TBL] [Abstract][Full Text] [Related]
23. Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study. Zöller B; Pirouzifard M; Sundquist J; Sundquist K J Thromb Thrombolysis; 2017 May; 43(4):469-475. PubMed ID: 27990607 [TBL] [Abstract][Full Text] [Related]
24. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study. Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402 [TBL] [Abstract][Full Text] [Related]
25. Cardiovascular risk factors and venous thromboembolism in Kingdom of Saudi Arabia: A meta-analysis and systemic review. Alsulami SS; El-Ghammaz A Niger J Clin Pract; 2023 Oct; 26(10):1399-1409. PubMed ID: 37929514 [TBL] [Abstract][Full Text] [Related]
26. Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort study. Desai RJ; Gagne JJ; Lii J; Liu J; Friedman S; Kim SC CMAJ; 2017 Nov; 189(47):E1438-E1447. PubMed ID: 29180383 [TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis. Mi Y; Yan S; Lu Y; Liang Y; Li C Medicine (Baltimore); 2016 Aug; 95(32):e4495. PubMed ID: 27512866 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis. Zhang J; Chen Z; Zheng J; Breusch SJ; Tian J Arch Orthop Trauma Surg; 2015 Jun; 135(6):759-72. PubMed ID: 25854654 [TBL] [Abstract][Full Text] [Related]
29. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Holst AG; Jensen G; Prescott E Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252 [TBL] [Abstract][Full Text] [Related]
30. Handgrip strength is not associated with risk of venous thromboembolism: a prospective cohort study. Kunutsor SK; Mäkikallio TH; Voutilainen A; Laukkanen JA Scand Cardiovasc J; 2020 Aug; 54(4):253-257. PubMed ID: 32281425 [No Abstract] [Full Text] [Related]
31. Immobilization and the risk of venous thromboembolism. A meta-analysis on epidemiological studies. Pottier P; Hardouin JB; Lejeune S; Jolliet P; Gillet B; Planchon B Thromb Res; 2009 Sep; 124(4):468-76. PubMed ID: 19481781 [TBL] [Abstract][Full Text] [Related]
32. Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in Children. Horton DB; Xie F; Chen L; Mannion ML; Curtis JR; Strom BL; Beukelman T Am J Epidemiol; 2021 Feb; 190(3):403-412. PubMed ID: 32902632 [TBL] [Abstract][Full Text] [Related]
33. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study. Chung WS; Lin CL; Sung FC; Lu CC; Kao CH Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321 [TBL] [Abstract][Full Text] [Related]
34. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis. Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536 [TBL] [Abstract][Full Text] [Related]
35. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case-control study. Wang MT; Liou JT; Huang YW; Lin CW; Wu GJ; Chu CL; Yeh CB; Wang YH Thromb Haemost; 2016 Jun; 115(6):1209-19. PubMed ID: 26941052 [TBL] [Abstract][Full Text] [Related]
36. Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models. Mahajerin A; Branchford BR; Amankwah EK; Raffini L; Chalmers E; van Ommen CH; Goldenberg NA Haematologica; 2015 Aug; 100(8):1045-50. PubMed ID: 26001789 [TBL] [Abstract][Full Text] [Related]
37. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Young G; Albisetti M; Bonduel M; Brandao L; Chan A; Friedrichs F; Goldenberg NA; Grabowski E; Heller C; Journeycake J; Kenet G; Krümpel A; Kurnik K; Lubetsky A; Male C; Manco-Johnson M; Mathew P; Monagle P; van Ommen H; Simioni P; Svirin P; Tormene D; Nowak-Göttl U Circulation; 2008 Sep; 118(13):1373-82. PubMed ID: 18779442 [TBL] [Abstract][Full Text] [Related]
38. Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose. Oedingen C; Scholz S; Razum O Thromb Res; 2018 May; 165():68-78. PubMed ID: 29573722 [TBL] [Abstract][Full Text] [Related]
39. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism. Klil-Drori AJ; Yin H; Tagalakis V; Aprikian A; Azoulay L Eur Urol; 2016 Jul; 70(1):56-61. PubMed ID: 26138040 [TBL] [Abstract][Full Text] [Related]
40. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. Dinger J; Assmann A; Möhner S; Minh TD J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]